| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/29/1996 | WO1996006172A1 Keto group introducing enzyme, dna coding for the same, and process for producing ketocarotenoid |
| 02/29/1996 | WO1996006171A2 New polypetides having a toxic activity against insects of the dipterae family |
| 02/29/1996 | WO1996006170A1 Method of treating birds with avian myelomonocytic growth factor |
| 02/29/1996 | WO1996006169A1 Human chemokine beta-9 |
| 02/29/1996 | WO1996006168A2 Retinoblastoma protein-interacting zinc finger proteins |
| 02/29/1996 | WO1996006167A1 Glutamate receptor |
| 02/29/1996 | WO1996006166A1 Improvements in or relating to binding proteins for recognition of dna |
| 02/29/1996 | WO1996006165A1 Genetically engineered swine cells |
| 02/29/1996 | WO1996006164A1 Method for isolating mutant cells |
| 02/29/1996 | WO1996006159A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/29/1996 | WO1996006112A1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 02/29/1996 | WO1996006111A1 Regulatable elimination of gene expression, gene product function and engineered host cells |
| 02/29/1996 | WO1996006107A1 Methods of identifying compounds useful for treating autoimmune diseases |
| 02/29/1996 | WO1996005866A2 Live vaccine for the treatment of tumour diseases |
| 02/29/1996 | WO1996005861A1 Compositions and methods for the treatment of body weight disorders, including obesity |
| 02/29/1996 | WO1996005859A1 Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections |
| 02/29/1996 | WO1996005858A1 Haemophilus adherence and penetration proteins |
| 02/29/1996 | WO1996005856A1 Human chemokine polypeptides |
| 02/29/1996 | WO1996005847A1 A method of sequencing proteins by epitope ordering and protein restriction mapping |
| 02/29/1996 | WO1996005722A1 High-affinity potassium uptake transporter from higher plants |
| 02/29/1996 | WO1996001614A3 Rna component of telomerase |
| 02/29/1996 | WO1996001324A3 Novel internal ribosome entry site, vector containing same and therapeutical use thereof |
| 02/29/1996 | WO1996001314A3 Ribozyme library, its production and use |
| 02/29/1996 | DE4431401A1 Lebendvakzine gegen Tumorerkrankungen Live vaccines against tumors |
| 02/29/1996 | DE4429942A1 Fattening biologically promotion useful esp. for female animals |
| 02/29/1996 | DE4428651C1 Verfahren zur Herstellung und Amplifikation von Nukleinsäuren Process for the preparation and amplification of nucleic acids |
| 02/29/1996 | CA2224401A1 High-affinity potassium uptake transporter from higher plants |
| 02/29/1996 | CA2198281A1 Genetic manipulation of plants to increase stored carbohydrates |
| 02/29/1996 | CA2198279A1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 02/29/1996 | CA2198234A1 Live vaccine for the treatment of tumour diseases |
| 02/29/1996 | CA2198219A1 Human chemokine polypeptides |
| 02/29/1996 | CA2198206A1 Human chemokine beta-9 |
| 02/29/1996 | CA2197890A1 Retinoblastoma protein-interacting zinc finger proteins |
| 02/29/1996 | CA2197864A1 Peptide libraries as a source of syngenes |
| 02/29/1996 | CA2197650A1 Method of treating birds with avian myelomonocytic growth factor |
| 02/29/1996 | CA2197562A1 Haemophilus adherence and penetration proteins |
| 02/29/1996 | CA2197493A1 A method of sequencing proteins by epitope ordering and protein restriction mapping |
| 02/29/1996 | CA2197242A1 Regulatable elimination of gene expression, gene product function and engineered host cells |
| 02/29/1996 | CA2196997A1 Glutamate receptor |
| 02/29/1996 | CA2196892A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/29/1996 | CA2196311A1 Genetically engineered swine cells |
| 02/29/1996 | CA2195562A1 Coupled amplification and ligation method |
| 02/29/1996 | CA2174534A1 Recombinant dnase b derived from streptococcus pyogenes |
| 02/28/1996 | EP0698667A1 Xylanase, microorganisms for its production, DNA molecules, process of preparation and use thereof |
| 02/28/1996 | EP0698666A2 Modified epimorphin |
| 02/28/1996 | EP0698665A2 Infectious Tick-Borne Encephalitis virus cDNA clone, recombinant vaccine derived therefrom and preparation thereof |
| 02/28/1996 | EP0698664A1 Alpha-1,3/4 fucosidase gene |
| 02/28/1996 | EP0698216A1 Methods of typing hepatitis c virus and reagents for use therein |
| 02/28/1996 | EP0698124A1 $i(IN VITRO) TRANSPOSITION OF ARTIFICIAL TRANSPOSONS |
| 02/28/1996 | EP0698123A1 Means for detecting familial colon cancer (fcc) |
| 02/28/1996 | EP0698117A1 Monoclonal antibodies against ck-mb |
| 02/28/1996 | EP0698116A1 Processes for producing an enzyme |
| 02/28/1996 | EP0698115A1 Methods and compositions relating to sterol regulatory element binding proteins |
| 02/28/1996 | EP0698109A1 Gene transfer into pancreatic and biliary epithelial cells |
| 02/28/1996 | EP0698108A1 Adenoviral vectors of animal origin and use thereof in gene therapy |
| 02/28/1996 | EP0698107A1 Gene therapy for haemophilia |
| 02/28/1996 | EP0698106A1 Marker gene |
| 02/28/1996 | EP0698105A1 Nucleotide sequences for the control of the expression of dna sequences in a cellular host |
| 02/28/1996 | EP0698104A1 Hippuricase gene |
| 02/28/1996 | EP0698103A1 CLONED DNA ENCODING A UDP-GALNAc:POLYPEPTIDE,N-ACETYLGALACTOS AMINYLTRANSFERASE |
| 02/28/1996 | EP0698102A1 Cholesterol-oxidase from brevibacterium sterolicum |
| 02/28/1996 | EP0698101A1 Hepatitis-c virus type 4, 5 and 6 |
| 02/28/1996 | EP0698100A1 Hybrid picornaviruses expressing chlamydial epitopes |
| 02/28/1996 | EP0698099A1 Method for the culture in vitro of differents stages of tissue parasites |
| 02/28/1996 | EP0698098A1 Method for obtaining male-sterile plants |
| 02/28/1996 | EP0698097A1 PRODUCTION OF ANTIBODIES OR (FUNCTIONALIZED) FRAGMENTS THEREOF DERIVED FROM HEAVY CHAIN IMMUNOGLOBULINS OF $i(CAMELIDAE) |
| 02/28/1996 | EP0698096A1 Expression of ntrk1-derived oncogenes in pc12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds |
| 02/28/1996 | EP0698095A1 Bmp-10 compositions |
| 02/28/1996 | EP0698094A1 Bmp-11 compositions |
| 02/28/1996 | EP0698093A1 VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE |
| 02/28/1996 | EP0698092A1 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 02/28/1996 | EP0698091A1 Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable |
| 02/28/1996 | EP0698089A1 Nucleic acid encoding amp-activated protein kinase |
| 02/28/1996 | EP0698087A1 Human t cell monoclone, process for its production and its use, diagnostic of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer |
| 02/28/1996 | EP0698086A1 Yeast strain and methods for expressing heterologous proteins in yeast |
| 02/28/1996 | EP0698082A1 Direct lysis buffer and the detection of hiv-1 plasma viremia |
| 02/28/1996 | EP0698042A1 Composition of antibodies against hepatitis b surface antigen |
| 02/28/1996 | EP0697893A1 Neural thread protein gene expression and detection of alzheimer's disease |
| 02/28/1996 | EP0697889A1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY |
| 02/28/1996 | EP0697888A1 Conserved motif of hepatitis c virus e2/ns1 region |
| 02/28/1996 | EP0511967B1 Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids-related complex (arc) employing anti-carbohydrate antibodies |
| 02/28/1996 | EP0362367B1 Osteogenic devices |
| 02/28/1996 | CN1117743A Method to predict active growth of bacteria adhered to a surface |
| 02/28/1996 | CN1117526A Recombinant single chain Fv antibody fragment and its use in the immunopurification of the recombinant hepatitus B virus surface antigen |
| 02/28/1996 | CN1117524A L-isoleucine-producing bacterium and method for preparing L-isoleucine through fermentation |
| 02/27/1996 | US5495071 Genetic engineering |
| 02/27/1996 | US5495070 Genetically engineering cotton plants for altered fiber |
| 02/27/1996 | US5495008 Oligonucleotide probes for detection of salmonella |
| 02/27/1996 | US5495007 Phloem-specific promoter |
| 02/27/1996 | US5495006 Antiviral polynucleotide conjugates |
| 02/27/1996 | US5495002 Tumor associated monoclonal antibody 123AV16 |
| 02/27/1996 | US5494999 For assaying, purifying or inducing cdw52 antibody |
| 02/27/1996 | US5494895 Scorpion peptide margatoxin with immunosuppressant activity |
| 02/27/1996 | US5494818 A fusion protein encoded by the dna which specifically cleaves in vitro between c-terminal residue of ubiquitin and n-terminal residue of protein |
| 02/27/1996 | US5494816 Enhanced indole biosynthesis |
| 02/27/1996 | US5494814 Ribonucleotides having two hybridizing regions with predetermined sequences capable of hybridizing with target dna |
| 02/27/1996 | US5494813 Nematode control with proteinase inhibitors |
| 02/27/1996 | US5494810 Genetic engineering |
| 02/27/1996 | US5494807 NYVAC vaccinia virus recombinants comprising heterologous inserts |
| 02/27/1996 | US5494806 A genetic engineered, hybridized probe consisting of an 18-polynucleotides sequence |